Clinical Trial Update: Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients [Phase 3]

View source ↗

Summary

A completed Phase 3 study assessing safety and efficacy of a Basiliximab, mycophenolate mofetil, cyclosporine microemulsion, and prednisone regimen in pediatric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• NEORAL (CYCLOSPORINE)
• PREDNISONE (Prednisone)
• Simulect (Basiliximab)

Snippet

Sponsor: Novartis | Conditions: Pediatric Kidney Transplantation | Phase 3 | Status: COMPLETED